CirculoGene

OverviewSuggest Edit

CirculoGene Theranostics is a molecular diagnostics company. It develops a droplet-volume next-generation sequencing (NGS) method to provide a genomic load analysis.
TypePrivate
Founded2015
HQBirmingham, AL, US
Websitecirculogene.com

Latest Updates

Employees (est.) (Sept 2021)43(+3%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at CirculoGene

Mike Mullen

Mike Mullen

President and CEO
Chen-Hsiung Yeh

Chen-Hsiung Yeh

Co-Founder, Chief Scientific Officer
Scott Rezek

Scott Rezek

Co-Founder, Chief Marketing Officer
Anthony L. Schmidt

Anthony L. Schmidt

Lab Director
Show more

CirculoGene Office Locations

CirculoGene has an office in Birmingham
Birmingham, AL, US (HQ)
3125 Independence Dr #301
Show all (1)

CirculoGene Financials and Metrics

Summary Metrics

Founding Date

2015

CirculoGene total Funding

$5.6 m

CirculoGene latest funding size

$2.1 m

Time since last funding

3 years ago
CirculoGene's latest funding round in November 2018 was reported to be $2.1 m. In total, CirculoGene has raised $5.6 m
Show all financial metrics

CirculoGene Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

CirculoGene Online and Social Media Presence

Embed Graph

CirculoGene Blogs

CIRCULOGENE Announces Lab Expansion in Florida

FOR IMMEDIATE RELEASE CIRCULOGENE Announces Lab Expansion in Florida Liquid Biopsy Company Laboratory Operations Are Growing in Pensacola  BIRMINGHAM, Ala. and Pensacola, Fla. (October 14, 2021) – CIRCULOGENE, an innovative medical technology company transforming precision medicine through the […] T…

CIRCULOGENE Announces Appointment of Richard B. Lanman, M.D., to Board of Directors

FOR IMMEDIATE RELEASE CIRCULOGENE Announces Appointment of Richard B. Lanman, M.D., to Board of Directors BIRMINGHAM, Ala. (October 4, 2021)– CIRCULOGENE, an innovative liquid biopsy company transforming precision medicine through the rapid delivery of actionable […] The post CIRCULOGENE Announces A…

CIRCULOGENE Announces Issuance of U.S. Patent for Method of Preparing Cell-Free Nucleic Acid Molecules by In Situ Amplification

Issued patent recognizes CIRCULOGENE’s novel method of enriching cfDNA without DNA isolation, extraction or purification, enabling “in situ” genetic manipulation of biofluid samples. BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine […] The p…

CIRCULOGENE Appoints Stephen Unger Chief Financial Officer

 BIRMINGHAM, Ala. – CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through rapid delivery of actionable results, announced today that Stephen Unger has joined the company as Chief Financial Officer. Mr. Unger has more […] The post CIRCULOGENE Appoints Stephe…

CirculoGene Frequently Asked Questions

  • When was CirculoGene founded?

    CirculoGene was founded in 2015.

  • Who are CirculoGene key executives?

    CirculoGene's key executives are Mike Mullen, Chen-Hsiung Yeh and Scott Rezek.

  • How many employees does CirculoGene have?

    CirculoGene has 43 employees.

  • Who are CirculoGene competitors?

    Competitors of CirculoGene include Diagtech, KBioBox and Cergentis.

  • Where is CirculoGene headquarters?

    CirculoGene headquarters is located at 3125 Independence Dr #301, Birmingham.

  • Where are CirculoGene offices?

    CirculoGene has an office in Birmingham.

  • How many offices does CirculoGene have?

    CirculoGene has 1 office.